Tests in Medical Technology

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

... well as the possibility of combining with other tests for HPV could play a key role in HPV genotyping. ... cancer. Today, more than 10 million HPV DNA tests are conducted annually, and the total number of HPV DNA tests is growing at a rate exceeding 35% per year. ...

Great Basin Scientific, Inc. Raises $3.6 Million in Bridge Funding to Prepare for Launch of First Product

... trials scheduled to begin in August. Future tests beyond hospital-acquired infections (HAIs) In ... for MRSA testing, the company is also developing tests for Group B Streptococcus - the most common cause ... targets in a single assay and no batching of tests required. About Great Basin ...

AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA

... to standard insulin therapy in pulmonary function tests NEW ORLEANS, June 6 /PRNewswire-FirstCall/ ... acting insulin with changes in pulmonary function tests comparable to usual antidiabetic treatment, ... Findings were based on pulmonary function tests (PFTs) over a 2-year period in subjects with type ...

Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW

... IBD Serology 7 diagnostic tests. "Genetic tests to rule out celiac disease are now readily ... who received multiple PROMETHEUS IBD Serology 7 tests within a two-year period. The overall rate of ... funding and widely-available genetic and blood tests for highly-specific antibodies. About IBD ...

Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting

... and commercializes new molecular diagnostic tests in oncology, announced that a recent study ... optimal treatment plans. Molecular diagnostic tests such as the THEROS CancerTYPE ID have ... validity and utility of molecular diagnostic tests such as the THEROS CancerTYPE ID continue to be ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... and weight decrease (0.6/0). Laboratory tests A total of 30 laboratory tests were regularly performed in CAPACITY. The ... observed between treatment groups on all tests were small. Regarding the overall safety ...

Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus

... agencies to help identify and develop diagnostic tests for emerging infectious diseases. Focus ... worldwide. Focus Diagnostics develops innovative tests and products to assist physicians in diagnosing ... diseases, and often provides the first diagnostic tests in the U.S. for emerging diseases, such as West ...

HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials

... one of the fastest and most sensitive viral load tests available, with the ability to detect and ... current molecular or PCR based diagnostic tests vary in their ability to detect and reliably ... assay is among the most sensitive viral load tests available today. The test has demonstrated the ...

Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program

... products into full commercialization. Current tests typically require the culture of live Lassa virus ... laboratory to produce reagents. These tests are expensive, laborious to produce, and not ... a five-year study designed to complete the tests for VHFs, some of which are potential ...

Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays

... developed and marketed a complete portfolio of tests for the identification and quantification of this ... worldwide a unique and comprehensive range of tests which targets the most molecular anomalies known ... With 2,400 employees, ARUP offers more than 2,000 tests and test combinations, ranging from routine ...

AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe

... protocol for all CE-IVD marked PNA FISH(R) tests in Europe. The fast protocol reduces the PNA ... product launch in May 2003, AdvanDx's PNA FISH tests have provided rapid identification of bloodstream ... studies have shown that implementing PNA FISH tests reduced time to reporting of pathogen ...

Prometheus and Rosetta Genomics Announce License and Collaboration Agreement

... Funding for development of these gastroenterology tests will be provided by Prometheus. "Prometheus ... We believe these three molecular diagnostic tests can help oncologists personalize therapy and are ... of Rosetta Genomics. "With Prometheus these tests now will be available across the U.S., and will ...

Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap

... QIAGEN donates one million tests to expand access to HPV screening in the world's ... and reproducible of all cervical cancer screening tests and was less demanding in terms of training and ... HPV testing QIAGEN's donation of 1 million HPV tests builds upon the company's programs to increase ...

A Joint Statement From America's Prostate Cancer Advocacy, Education, and Support Organizations

... and to request the appropriate use of PSA and DRE tests until better options are available. Further clinical action based on results of these tests is also a matter for serious discussion between ... emphasis on the development of new clinical tests that can differentiate between those men at ...

Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State

... disorders, which conventional laboratory tests may fail to detect. "With approval by New ... extensive cytogenetic and/or FISH testing. aCGH tests are also more efficient, as multiple tests are required to generate the same amount of ...

IBT Laboratories to Launch New Pneumococcal Antibody Avidity Test at AAAAI Meeting, Booth 729

... Test builds on company's suite of tests to evaluate immune function LENEXA, Kan., ... - today, one of the most-widely prescribed tests used to determine why a patient has recurrent ... of those antibodies. Together, these pneumococcal tests provide more insight into the strengths and ...

Pharmaxis Announces New Drug Application Submission for Aridol(TM)

... a bronchial challenge test. Bronchial challenge tests are designed to help in the correct diagnosis and ... Asthma Management Guidelines. It is one of the tests recommended by the World Anti-Doping Agency, and ... (GP). Yet GPs currently rely upon older tests that are often inaccurate and cumbersome to ...

Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis

... plans to use a similar approach to develop tests that may one day be used by physicians as an aid ... company's proprietary Leumeta(TM) portfolio of tests helps physicians identify and analyze genetic ... is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology ...

deCODE Receives California Clinical Laboratory License

... process deCODE's DNA-based reference laboratory tests for gauging individual risk of major public ... in bringing to market the reference laboratory tests and direct-to-consumer scans that enable ... to delivering only the best validated tests and the highest quality results, all in-house. We ...

Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor

... HCV therapies, Abbott also offers laboratory tests for patient diagnosis, blood screening tests for hospitals and blood banks, and molecular diagnostic tests to measure HCV viral load and resistance. ...

Vermillion Presents Critical Data From Its OVA1 Clinical Trial

... Vermillion has multiple ovarian cancer diagnostic tests in development. The most advanced of Vermillion's ... Additionally, studies are underway to develop tests with the capability of detecting early-stage ... commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve ...

Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening

... used serological HIV tests. Conventional HIV tests detect HIV-specific antibodies in blood or oral ... Public Health tested 14,005 MSM with HIV antibody tests from 2003 through 2008. Overall, 328 individuals ... broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, ...

Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers

... funding to develop these potentially valuable tests is not readily available today and as such, work ... dedicated to developing rapid, non-invasive tests for the early detection of life-threatening ... skin cholesterol tests. The Company's cancer tests include ColorectAlertTM, LungAlertTM and a breast ...

Lenetix Launches Screening Study of New Down Syndrome Test

... accuracy. Patients deemed "at risk" by these tests are generally referred for genetic counseling and ... greatly reduce the number of unnecessary invasive tests -- and the fetal losses they can cause. ... has nearly 30 years experience in developing new tests used by healthcare providers and researchers ...

Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test

... funding and resources. The NuroPro tests will be offered by Transgenomic in its ... depth to complement our array of genetic tests in neurology." Power3 Medical CEO Helen R. ... expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more ...

Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update

... company developing clinical diagnostic laboratory tests and drugs to diagnose, treat and prevent ... test to identify patients with Hp2-2 diabetes. tests which identify patients with Hp2-2 diabetes may ... development of Synvista Therapeutics' diagnostic tests and product candidates, and other risks ...

Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed

... and partners we design, develop and manufacture tests under FDA Quality System Regulations and ISO 13485:2003 guidelines. These tests have been, and will be, designed to run on a ... is in the production of superior performing tests with significantly faster time to market than ...

Gene Abnormality Found to Predict Childhood Leukemia Relapse

... likely to provide the basis for future diagnostic tests to assess the risk of treatment failure. By using ... useful and will complement existing diagnostic tests and measurement of minimal residual disease ... may be necessary to develop a panel of different tests to detect IKAROS lesions and identify which ...

Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients

... the ability of laboratories to offer diagnostic tests to physicians and patients. The request ... (FDA) should regulate all laboratory developed tests (LDTs) "for use in drug or biologic therapeutic ... "to ensure that claims made for the tests are scientifically proven." Genentech wrongly ...

Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium

... and commercializes new molecular diagnostic tests in oncology, reported today findings from three ... develops and commercializes molecular diagnostic tests for cancer patients. Leveraging its unique ... algorithms, bioTheranostics provides innovative tests to the oncology community that drive ...

Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients

... and pathology tests. All MammaPrint(R) tests are conducted in Agendia's CLIA-certified ... tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor ... markets four products, with several new genomic tests under development. In addition, ...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

... and pathology tests. All MammaPrint tests are conducted in Agendia's CLIA-certified ... tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor ... markets four products, with several new genomic tests under development. In addition, ...

Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium

... and pathology tests. All MammaPrint tests are conducted in Agendia's CLIA-certified ... tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor ... markets four products with several new genomic tests under development. In addition, ...

GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP

... must have regular monitoring of serum liver tests (see Laboratory Monitoring below). Discontinue ... reintroduce PROMACTA and measure serum liver tests weekly during the dose adjustment phase. If liver ... of PROMACTA. Liver tests: Monitor serum liver tests (ALT, AST, total and fractionated bilirubin) ...

IBT Laboratories Expands its Menu of Tests for Immune Deficiency

... assays, announced that it has launched two tests to evaluate the response of patients whose ... Officer, John F. Halsey, Ph.D., these two tests provide physicians with much greater insight into ... need to be evaluated. Previously, these kinds of tests were only used by the research community, and ...

GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.

... is commonly available today. There are other PCR tests available, but what makes GeneThera's service ... service. According to the company; "the other PCR tests that are available require the purchase of a test ... This platform enables GeneThera to offer tests that are presently not available from other ...

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

... must have regular monitoring of serum liver tests (see Laboratory Monitoring below). ... reintroduce PROMACTA and measure serum liver tests weekly during the dose adjustment phase. If liver ... of PROMACTA. Liver tests: Monitor serum liver tests (ALT, AST, total and fractionated bilirubin) ...

Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.

... has a broad program of ovarian cancer diagnostic tests in development. Studies are underway to verify the capability of such tests to detect early-stage ovarian cancer, predict ... of novel high-value diagnostic tests that help physicians diagnose, treat and improve ...

Comprehensive Safety Tests Published on Ruyan(R) Smoking Alternatives

... tests Conducted in New Zealand and Canada Find Ruyan ... only and specifically to Ruyan products. The tests were conducted by Dr. Murray Laugesen of Health ... in New Zealand and Canada. Ruyan funded the tests and the report, but had no role in the design of ...

Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests

... and Specificity than Other Rapid HBSAG tests and FirstVue(TM) ... was the preferred ... testing using HBSAG positive samples. Those tests were then compared in a comprehensive evaluation ... and the highest specificity (99.7%) among all the tests evaluated. In addition, the evaluation indicated ...